SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOxford Instruments Regulatory News (OXIG)

Share Price Information for Oxford Instruments (OXIG)

Share Price is delayed by 15 minutes
Get Live Data
2,878.00    130.00 (4.73%)
Bid:
2,846.00
Ask:
2,862.00
Spread: 16.00 (0.562%)
Market Cap: £1.59b
OXIG Live PriceLast checked at - London Stock Exchange

Intraday Oxford Instruments Share Chart

Interim Management Statement

19 Jan 2012 07:00

RNS Number : 8030V
Oxford Instruments PLC
19 January 2012
 



Oxford Instruments plc

 

Interim Management Statement

 

19 January 2012

 

Oxford Instruments plc, a leading provider of high technology tools and systems for industry and research, today issues an Interim Management Statement which covers the period from 1 October 2011 to date.

Orders within both our Research and Industrial markets remained robust with the exception that, as expected, orders for High Brightness LED related equipment within our Plasma Technology business unit have fallen as overcapacity in this industry takes effect. Despite this, orders, sales and profits for the Group for the year to date and for the third quarter are ahead of the corresponding period last year and consistent with our expectations.

On 20 October 2011 the Group disposed of a non-core Industrial product line that we produced for a single customer, to that customer. A consideration of £7.1 million was paid on completion, with a further £1.0 million receivable on the completion of a Transitional Services Agreement.

On 4 November 2011 the Group announced the acquisition of Platinum Medical Imaging LLC (Platinum) for an initial debt free, cash free consideration of US$18 million with a deferred element of up to US$37 million payable over three years dependent on its performance over that period. The combination of Platinum with our existing MRI Service business in North America significantly strengthens the Group's Service Sector offering, and its integration is progressing to plan.

Save as described in this statement, there has been no significant change in the financial position of the Group in the period.

Our broad spread of geographies and technologies, and our strong pipeline of new products should help us to remain resilient in the event of a global economic downturn. The Board anticipates that Oxford Instruments will continue to make good progress in line with its expectations for the remainder of the financial year and consistent with its 14 cubed objectives.

 

Enquiries:

 

 

Oxford Instruments plc Tel: 01865 393200

Jonathan Flint, Chief Executive

Kevin Boyd, Group Finance Director

 

MHP Tel: 020 3128 8100

Rachel Hirst / Ian Payne

 

 

This Interim Management Statement contains certain forward-looking statements which have been made by the Directors in good faith using information available up until the date they approved the Statement. Forward-looking statements should be regarded with caution as by their nature such statements involve risk and uncertainties relating to events and circumstances that may occur in the future. Actual results may differ from those expressed in such statements, depending on the outcome of these uncertain future events.

 

 

Notes to Editors

Oxford Instruments designs, supplies and supports high-technology tools and systems with a focus on research and industrial applications. It provides solutions needed to advance fundamental physics research and its transfer into commercial nanotechnology applications. Innovation has been the driving force behind Oxford Instruments' growth and success for over 50 years, and its strategy is to effect the successful commercialisation of these ideas by bringing them to market in a timely and customer-focused fashion. 

The first technology business to be spun out from Oxford University over fifty years ago, Oxford Instruments is now a global company with over 1900 staff worldwide and is a member of the FTSE250 index on the London Stock Exchange (OXIG). Its objective is to be the leading provider of new generation tools and systems for the research and industrial sectors.

This involves the combination of core technologies in areas such as low temperature, high magnetic field and ultra high vacuum environments, Nuclear Magnetic Resonance, X-ray, electron and optical based metrology, and advanced growth, deposition and etching.

Oxford Instruments aims to pursue responsible development and deeper understanding of our world through science and technology. Its' products, expertise, and ideas address global issues such as energy, environment and health.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSBRGDBGDBBGDI
Date   Source Headline
24th Mar 20252:35 pmPRNHolding(s) in Company
7th Mar 20259:00 amPRNHolding(s) in Company
6th Mar 20258:30 amPRNHolding(s) in Company
5th Mar 202511:37 amPRNHolding(s) in Company
5th Mar 202510:40 amPRNDirector/PDMR Shareholding
3rd Mar 202510:59 amPRNTotal Voting Rights
17th Feb 20258:52 amPRNDirectorate Change
10th Feb 20253:26 pmPRNDirector/PDMR Shareholding
3rd Feb 20251:30 pmPRNTotal Voting Rights
13th Jan 202511:09 amPRNDirector/PDMR Shareholding
9th Jan 20257:00 amRNSChief Financial Officer succession
7th Jan 20254:48 pmPRNDirector Declaration
3rd Jan 202511:39 amPRNBlocklisting - Interim Review
2nd Jan 202511:38 amPRNTotal Voting Rights
13th Dec 202412:15 pmRNSHolding(s) in Company
12th Dec 20243:41 pmRNSDirector/PDMR Shareholding
2nd Dec 202411:00 amPRNTotal Voting Rights
12th Nov 202412:30 pmPRNDirector/PDMR Shareholding
12th Nov 20247:00 amRNSHalf-Year Results
8th Nov 202411:54 amPRNHolding(s) in Company
23rd Oct 20242:30 pmPRNHolding(s) in Company
16th Oct 20247:00 amRNSHalf Year Trading Update
14th Oct 20248:54 amPRNDirector/PDMR Shareholding
1st Oct 202411:31 amPRNTotal Voting Rights
11th Sep 20243:48 pmPRNDirector/PDMR Shareholding
2nd Sep 20248:39 amPRNTotal Voting Rights
14th Aug 20249:09 amPRNDirector/PDMR Shareholding
12th Aug 20244:37 pmPRNDirector/PDMR Shareholding
9th Aug 20241:15 pmPRNDirector/PDMR Shareholding
1st Aug 202410:57 amPRNTotal Voting Rights
26th Jul 20249:59 amPRNAnnual General Meeting 2024 Results
25th Jul 20249:31 amPRNDirector/PDMR Shareholding
24th Jul 20249:00 amPRNDirector Declaration
23rd Jul 20244:00 pmPRNDirector/PDMR Shareholding
18th Jul 20244:32 pmPRNHolding(s) in Company
18th Jul 20244:29 pmPRNHolding(s) in Company
18th Jul 20248:00 amPRNBlock Listing Application
12th Jul 20241:04 pmPRNHolding(s) in Company
12th Jul 202410:05 amPRNDirector/PDMR Shareholding
2nd Jul 20242:11 pmPRNBlocklisting - Interim Review
1st Jul 202412:21 pmPRNTotal Voting Rights
1st Jul 20249:14 amRNSCompletion of acquisition of FemtoTools AG
25th Jun 202412:51 pmPRNHolding(s) in Company
25th Jun 202410:40 amPRNPublication of Annual Report 2024 and Notice of Annual General Meeting 2024
11th Jun 202411:18 amPRNDirector/PDMR Shareholding
11th Jun 20247:01 amRNSOxford Instruments plc to acquire FemtoTools AG
11th Jun 20247:00 amRNSPreliminary Results
6th Jun 20241:05 pmPRNHolding(s) in Company
5th Jun 20248:24 amPRNDirectorate Change
3rd Jun 20241:35 pmPRNHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.